When is QT prolongation antiarrhythmic and when is it proarrhythmic?

The American Journal of Cardiology

Volumn 63, Issue 12, 1989, Pages 867-869

  Singh, Bramah N ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI ARRHYTHMIA AGENTS; ANTIARRHYTHMIC AGENT;

EDITORIAL; ELECTROCARDIOGRAPHY; HEART ARRHYTHMIA; HUMAN; PATHOPHYSIOLOGY;

ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIA; ELECTROCARDIOGRAPHY; HUMAN; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.;

EID: 0024652653     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9149(89)90059-3     Document Type: Editorial

References (23)

1. Long QT: good, bad or indifferent?
2. Idiopathic long QT syndrome: progress and questions
3. Quinidine syncope: paroxysmal ventricular fibrillation occurring during treatment of chronic atrial arrhythmias
4. La tachycardie ventriculaire a deux foyers opposes variables
5. Incidence and clinical features of the quinidine-associated long QT syndrome implications for patient care
6. Ventricular arrhythmias and hypokalemia
7. A third class of antiarrhythmic action. Effects on atrial and ventricular intracellular potentials and other pharmacologic actions on cardiac muscle, of MJ 1999 and AH 3474
8. The effect of amiodarone, a new antianginal drug, on cardiac muscle
9. Nine cases of torsades de pointes with bepridil administration
10. Comparison of lidoflazine and quinidine in prophylactic treatment of arrhythmias
11. Incidence and clinical relevance of QT prolongation caused by the new selective serotonin antagonist ketanserin
12. Acute and chronic effects of ketanserin on the electrophysiological properties of isolated rabbit ventricular myocardium: particular reference to repolarization
13. Cardiac electrophysiologic effects of intravenous ketanserin in humans
14. Comparative mechanisms of action of antiarrhythmic drugs
15. Clofilium
16. Long QT interval and ventricular tachycardia of “torsade de pointes” type in hypothyroidism
17. Side effect profile of amiodarone and approaches to optimal dosing
18. Electropharmacologic properties of amiodarone
19. Barium-induced non-driven action potentials as a model of triggered automaticity and early afterdepolarizations: differing effects of amiodarone, lidocaine and quinidine and significance of slow channel-activity
20. Effects of thyroid hormone on the action potential and membrane currents of guinea pig ventricular myocytes
21. The effects of altered thyroid state on atrial intracellular potentials
22. Control of arrhythmias by selective lengthening of cardiac repolarization: theoretical considerations and clinical observations